Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 9 clinical trials
Featured trial
Venous Thromboembolism in Primary Pancreatic Tumour Resection (PaTR-VTE)

This study will evaluate the development of venous thromboembolism (VTE) and possible determinants in patients with primary pancreatic cancer undergoing pancreatic cancer resection.

  • 0 views
  • 24 Nov, 2025
Sulodexide VESSEL for the Prevention of Recurrent Venous Thromboembolism (The Jason Study)

The study aims at optimizing extended management of elderly patients (> 75 years) with at least one of the known bleeding risk factor, who suffered from first episode of venous thromboembolism of the lower extremity (proximal deep vein thrombosis with or without pulmonary embolism) (VTE). Patients were randomized to receive …

thrombosis
thrombocytopenia
renal failure
venous thromboembolism
pulmonary embolism
  • 0 views
  • 19 Feb, 2024
  • 1 location
Intensive Rhythm Monitoring to Decrease Ischemic Stroke and Systemic Embolism - the Find-AF 2 Study

Patients who have suffered a stroke are having an increased risk of having recurrent stroke in the future. This risk of stroke is increased by atrial fibrillation, which often "comes and goes" (called paroxysmal) and hence escapes routine diagnostics. The hypothesis of Find-AF 2 is that enhanced (evaluation in a …

cardiac monitoring
atrial fibrillation
holter monitor
stroke
embolism
  • 0 views
  • 19 Feb, 2024
  • 7 locations
Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism

The clinical significance of pulmonary embolism (PE) limited to the subsegmental pulmonary arteries, so called isolated subsegmental pulmonary embolism (SSPE), remains controversial. Whether isolated SSPE represents "true" PE, a clinically more benign form of PE, a physiologic lung clearing process, or a false positive result (artifact) is currently unclear and …

thrombosis
anticoagulation treatment
venous thromboembolism
lung diseases
pulmonary embolism
  • 0 views
  • 19 Feb, 2024
  • 31 locations
Acute Atrial Fibrillation and Flutter Treated Electively

All patients who have not received adequate anticoagulation for three weeks prior to the delayed cardioversion will undergo a transesophageal cardiac ultrasound to ensure they are not in excess risk for thromboembolic events. Patients randomized to elective treatment have the possibility to opt-out and undergo acute cardioversion if their symptoms …

arrhythmia
fibrillation
antiarrhythmic drug
thromboembolism
atrial flutter
  • 0 views
  • 19 Feb, 2024
  • 4 locations
Post-marketing Surveillance of EVRENZO Tablets (Roxadustat) in Dialysis-dependent Patients With Renal Anemia

The purpose of this study is to assess the safety and efficacy, including the incidence of thromboembolism, in renal anemia patients on dialysis treated with roxadustat (EVRENZO Tablets) in actual clinical settings.

anemia
dialysis
  • 0 views
  • 19 Feb, 2024
  • 47 locations
Thromboembolic Events in Severe COVID-19 Patients

The main objective of this study is to describe the incidence of thromboembolic events in a population of patients hospitalized in intensive care units in France for severe COVID-19. The secondary objective of this study is to describe the evolution of hemostasis parameters during the first two weeks of intensive …

acute respiratory syndrome (sars)
thromboembolism
haemostasis
covid-19
  • 0 views
  • 19 Feb, 2024
  • 1 location
Sequelae of Sars-CoV-2 Infections

By the end of 2019 a new coronavirus, named SARS-CoV-2, was discovered in patients with pneumonia in Wuhan, China. In the following weeks and months the virus spread globally, having a tremendous impact on global health and economy. To date, no vaccine or therapy is available. Severe courses of the …

acute respiratory syndrome (sars)
coronavirus infection
cardiovascular system
pneumonia
  • 0 views
  • 19 Feb, 2024
  • 1 location
The Safety and Efficacy of Radiofrequency Ablation After Left Atrial Appendage Occlusion.

Objective: To evaluate the safety and efficacy of transcatheter atrial fibrillation ablation 1 month after WATCHMAN FLX left atrial appendage closure in patients with nonvalvular atrial fibrillation.

  • 0 views
  • 19 Aug, 2025